Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

PRESS RELEASE : Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus

10/20/2021 | 08:01am EST

DGAP-News: Champions Oncology, Inc. / Key word(s): Miscellaneous Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus 2021-10-20 / 14:00 The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus

HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned OpenZone Life Sciences Campus in Bresso, Italy, on the doorstep of Milan.

After launching preclinical and clinical GCLP-compliant biomarker services in 2019, Champions Oncology has rapidly grown to be a leader in the industry by providing scientific expertise, unparalleled quality, and innovative data analytics.

OpenZone is a scientific campus conceived by the healthcare company Zambon to create value in the field of Health, by fostering community, competencies, and capital. With the arrival of Champions Oncology, it is home to 34 enterprises and is undergoing a substantial expansion phase. Thanks to a total investment of around 65 million euros, OpenZone will double in size by 2022, growing to cover a surface area of 37,000 square meters with the capacity to host up to 1,200 people.

"Expanding our laboratory footprint into Europe is a tremendous milestone for Champions," said Ronnie Morris, MD, CEO of Champions Oncology. "Having local/regional access to clinical trial patient samples, some which require less than 24 hours to be processed to achieve accurate readouts, will provide a solution to our clients and also drive growth for our clinical biomarker business in the years to come."

With the unprecedented growth of clinical trials in Europe and the requirement of proximity to access expert biomarker analytical services, Champions is well positioned to serve existing as well as new European clients within the Biotech and Pharmaceutical industries with its expertise in high-dimensional flow cytometry (up to 24-colors) and other analytical techniques as part of Champions' growing portfolio.

About Champions Oncology, Inc.

Champions Oncology is a data-driven research organization, with headquarters in the United States, that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based discovery platforms, unique oncology software solutions, and innovative and proprietary experimental tools such as in vivo, ex-vivo and biomarker platforms. For more information, please visit www.ChampionsOncology.com.

Media Contact:

Rachel Bunting, MS, MBA Sr. Director, Head of Marketing Champions Oncology, Inc. Marketing@championsoncology.com

About OpenZone

OpenZone is the campus, on the doorstep of Milan, dedicated to Health and founded on an approach geared towards open innovation. Conceived by the healthcare company Zambon to build bridges between different languages and worlds, OpenZone mission is to "uniquely create value in Healthcare, by fostering community, competencies and capital". Today the campus is home to 34 enterprises, including some of the foremost biotechnology, pharmaceutical and advanced gene therapy companies, all with a strong penchant for innovation. Work is underway to expand the campus, which, thanks to a total investment of around 65 million euros, will double in size by 2022, growing to cover a surface area of 37,000 square metres, with the capacity to host up to 1,200 people.

OpenZone works closely with all stakeholders in the health sector, to ensure that Milan and Lombardy are increasingly recognized internationally as a territory of excellence for life sciences. Learn more on www.openzone.it/ en .

Media Contacts:

Marco Allegrini Tel: +39 347 339 5615 E: marco.allegrini@zambongroup.com E: ufficiostampa@openzone.it

Image Building Cristina Fossati / Angela Fumis Tel. +39 02 89011300 E: zambon@imagebuilding.it

SOURCE: Champions Oncology, Inc.

-----------------------------------------------------------------------------------------------------------------------

2021-10-20 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

-----------------------------------------------------------------------------------------------------------------------

1242003 2021-10-20

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1242003&application_name=news

(END) Dow Jones Newswires

October 20, 2021 08:00 ET (12:00 GMT)

Latest news "Companies"
08:01aSelective Insurance and the Selective Insurance Group Foundation Celebrate the Holiday Season With Their Second Annual Week of Giving to Support Nonprofit Organizations
PR
08:01aMEREO BIOPHARMA : Reports Interim Data from ACTIVATE Phase 1b/2 Open Label Study of etigilimab Anti-TIGIT Antibody in combination with Nivolumab in Solid Tumors - Form 6-K
PU
08:01aUnion Pacific Corporation CFO Jennifer Hamann to Address the 2021 BMO Growth & ESG Conference
PR
08:01aTriEye Appoints Dr. Hans Rijns, Former NXP Semiconductors CTO and Semiconductor Industry Veteran, as Board Advisor
PR
08:01aECOWAS Commission and UNECA organize a technical review of the draft Regional AfCFTA Implementation Strategy
PU
08:01aPONSSE OYJ : Plc and Globe Hope – together towards a better future
PU
08:01aZimmer Biomet Announces Early Results and Upsize of its Tender Offers for Certain Outstanding Debt Securities
PR
08:01aELINOIL HELLENIC PETROLEUM S A : Announcement 9477/2021 (no English translation available)
PU
08:01aCAST Achieves AWS Migration and Modernization Competency Status
GL
08:01aCAST Achieves AWS Migration and Modernization Competency Status
GL
Latest news "Companies"